Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +12.15% | +34.83% | -20.53% |
Financials (USD)
Sales 2024 * | 772M | Sales 2025 * | 847M | Capitalization | 746M |
---|---|---|---|---|---|
Net income 2024 * | -262M | Net income 2025 * | -187M | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.88 x |
P/E ratio 2024 * |
-3.33
x | P/E ratio 2025 * |
-4.76
x | Employees | 3,930 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.99% |
Latest transcript on OPKO Health, Inc.
1 day | +12.15% | ||
1 week | +34.83% | ||
Current month | +20.00% | ||
1 month | +14.29% | ||
3 months | -24.05% | ||
6 months | -23.08% | ||
Current year | -20.53% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 07-02-28 |
Elias Zerhouni
PSD | President | 71 | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Roger Medel
BRD | Director/Board Member | 77 | 20-12-17 |
Director/Board Member | 68 | 07-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.07% | 464 M€ | -.--% | ||
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.209 | +12.99% | 28,867,498 |
24-03-27 | 1.07 | +5.94% | 11,816,653 |
24-03-26 | 1.01 | 0.00% | 3,616,364 |
24-03-25 | 1.01 | +4.71% | 29,847,768 |
24-03-22 | 0.9646 | +3.72% | 25,547,040 |
Delayed Quote Nasdaq, March 28, 2024 at 04:15 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.53% | 746M | |
-8.32% | 9.16B | |
-9.54% | 3.67B | |
+39.95% | 3.57B | |
-4.12% | 2.59B | |
-12.21% | 2.27B | |
-2.84% | 1.94B | |
-16.85% | 1.66B | |
-25.37% | 1.53B | |
-7.98% | 1.09B |